Please login to the form below

Not currently logged in
Email:
Password:

Yescarta

This page shows the latest Yescarta news and features for those working in and with pharma, biotech and healthcare.

Kite’s CAR-T therapy Yescarta granted EC approval in second-line lymphoma

Kite’s CAR-T therapy Yescarta granted EC approval in second-line lymphoma

Additionally, Yescarta demonstrated a 2.5 fold increase in patients who were alive at two years without disease progression or need for additional cancer treatment versus SOC. ... Moreover, improvements in EFS with Yescarta were consistent across key

Latest news

More from news
Approximately 15 fully matching, plus 58 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...